Monitor court approval and closing conditions for the ABC proceeding. If the deal closes, cbdMD's revenue base could more than double, significantly reducing CBD concentration risk. Watch for any disclosure of the purchase price or financing terms, which would clarify potential dilution.
Price Chart
Executive Summary
cbdMD has entered a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab (including Twinlab, Reserveage, Metabolife, and Alvita Tea) through an assignment for the benefit of creditors proceeding. The combined unaudited trailing twelve-month revenue as of June 2026 is approximately $30 million, representing a ~40% increase over cbdMD's standalone revenue, though the purchase price is not disclosed. The transaction is subject to court approval and customary closing conditions, and if completed, would significantly diversify cbdMD's revenue away from hemp-derived products into legacy supplements and wellness categories.
Key Facts
- cbdMD enters definitive asset purchase agreement to acquire Twinlab brands (Twinlab, Reserveage, Metabolife, Alvita Tea) via an ABC proceeding.
- Combined unaudited trailing twelve months revenue ending June 2026 totals approximately $30 million, a ~40% increase over cbdMD's standalone revenue.
- Acquisition is subject to court approval and customary closing conditions; purchase price not disclosed.
- Deal expands cbdMD's platform into supplements, sports nutrition, weight management, longevity, and beauty, reducing reliance on CBD/hemp.
Financial Impact
Combined trailing twelve-month revenue of ~$30M (40% increase over cbdMD standalone); purchase price undisclosed.
Risk Factors
- Court may not approve the ABC sale or may require an auction process, potentially derailing or altering terms.
- Integration of distressed brands and legacy obligations could strain cbdMD's small balance sheet.
- No purchase price disclosed; if financed via equity, dilution could offset revenue gains.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302867135 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 7w ago | Press Release | $0.5000 $0.4530 | ▼ −9.40% | ▼ −9.32% | $0.3711 (−25.78%) |
Sep 2, 2026 7w ago | 8-K | $0.5000 $0.4530 | ▼ −9.40% | ▼ −9.32% | $0.3711 (−25.78%) |
Aug 10, 2026 11w ago | Press Release | $0.5660 $0.4997 | ▼ −11.71% | ▼ −10.80% | $0.3711 (−34.43%) |
May 20, 2026 22w ago | 8-K | $0.7790 $0.6901 | ▼ −11.41% | ▼ −11.75% | $0.3711 (−52.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers